Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Omnilogic Plus
- Development stage
- Unknown
- Lead developer
- Institut AllergoSan
- Administration
- Oral
01
Overview
Omnilogic Plus (marketed as OMNi-LOGiC® PLUS) is a prebiotic dietary supplement developed by Institut AllergoSan, a microbiome research center based in Austria and Germany. It is formulated as a fiber powder designed to support intestinal health, gut barrier function, and metabolic balance. The product contains a combination of short-chain fructooligosaccharides (FOS), galactooligosaccharides (GOS), and konjac root extract (glucomannan), which serve as nutritional substrates for beneficial commensal gut bacteria. Specifically, it is intended to promote the growth of *Akkermansia muciniphila* and *Faecalibacterium prausnitzii*, species associated with a healthy mucus layer and anti-inflammatory effects in the gut. The supplement is further enriched with vitamins B2 and D, as well as the minerals calcium and zinc, to support digestive enzyme function and mucosal integrity. It is classified as a dietary supplement and meets FDA GRAS (Generally Recognized As Safe) criteria.
- Brand names
- Omnilogic PlusOMNi-LOGiC PLUS
- Other names
- OMNi-LOGiC® PLUS
Beyond the preview
Go deeper on Omnilogic Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Omnilogic Plus.